PNC Financial Services Group’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$344K Sell
4,587
-49
-1% -$3.15K ﹤0.01% 2068
2026
Q1
$261K Sell
4,636
-96
-2% -$6.25K ﹤0.01% 2147
2025
Q4
$379K Buy
4,732
+614
+15% +$41.3K ﹤0.01% 1864
2025
Q3
$201K Sell
4,118
-521
-11% -$32.2K ﹤0.01% 2296
2025
Q2
$346K Buy
4,639
+11
+0.2% +$728 ﹤0.01% 1823
2025
Q1
$294K Sell
4,628
-4,175
-47% -$284K ﹤0.01% 1906
2024
Q4
$687K Sell
8,803
-528
-6% -$42.4K ﹤0.01% 1337
2024
Q3
$750K Buy
9,331
+89
+1% +$7.19K ﹤0.01% 1297
2024
Q2
$765K Sell
9,242
-794
-8% -$69.8K ﹤0.01% 1255
2024
Q1
$857K Buy
10,036
+1,403
+16% +$110K ﹤0.01% 1230
2023
Q4
$738K Sell
8,633
-481
-5% -$41.6K ﹤0.01% 1299
2023
Q3
$816K Buy
9,114
+966
+12% +$86.2K ﹤0.01% 1209
2023
Q2
$694K Buy
8,148
+454
+6% +$38.4K ﹤0.01% 1351
2023
Q1
$637K Buy
7,694
+805
+12% +$65.2K ﹤0.01% 1392
2022
Q4
$542K Sell
6,889
-401
-6% -$32.2K ﹤0.01% 1475
2022
Q3
$541K Sell
7,290
-667
-8% -$47.9K ﹤0.01% 1465
2022
Q2
$519K Sell
7,957
-4,845
-38% -$287K ﹤0.01% 1509
2022
Q1
$809K Buy
12,802
+387
+3% +$21K ﹤0.01% 1363
2021
Q4
$658K Buy
12,415
+256
+2% +$15.6K ﹤0.01% 1531
2021
Q3
$859K Buy
12,159
+2,732
+29% +$172K ﹤0.01% 1278
2021
Q2
$628K Buy
9,427
+1,710
+22% +$121K ﹤0.01% 1462
2021
Q1
$857K Sell
7,717
-2,292
-23% -$284K ﹤0.01% 1235
2020
Q4
$1.19M Sell
10,009
-164
-2% -$17.7K ﹤0.01% 1050
2020
Q3
$888K Buy
10,173
+3,143
+45% +$275K ﹤0.01% 1090
2020
Q2
$630K Sell
7,030
-194
-3% -$19.6K ﹤0.01% 1252
2020
Q1
$720K Buy
7,224
+532
+8% +$57.7K ﹤0.01% 1112
2019
Q4
$768K Sell
6,692
-45,123
-87% -$5.46M ﹤0.01% 1215
2019
Q3
$6.54M Sell
51,815
-18,549
-26% -$2.35M 0.01% 601
2019
Q2
$8.47M Buy
70,364
+63,155
+876% +$6.21M 0.01% 565
2019
Q1
$631K Buy
7,209
+2,234
+45% +$203K ﹤0.01% 1519
2018
Q4
$497K Buy
4,975
+796
+19% +$83.6K ﹤0.01% 1555
2018
Q3
$480K Buy
4,179
+2,453
+142% +$254K ﹤0.01% 1689
2018
Q2
$156K Sell
1,726
-190
-10% -$16K ﹤0.01% 2353
2018
Q1
$140K Sell
1,916
-56
-3% -$3.84K ﹤0.01% 2371
2017
Q4
$114K Buy
1,972
+48
+2% +$2.53K ﹤0.01% 2500
2017
Q3
$86K Buy
1,924
+643
+50% +$26.7K ﹤0.01% 2615
2017
Q2
$51K Buy
1,281
+131
+11% +$5.38K ﹤0.01% 2884
2017
Q1
$46K Buy
1,150
+350
+44% +$13.7K ﹤0.01% 2926
2016
Q4
$32K Sell
800
-185
-19% -$6.97K ﹤0.01% 3032
2016
Q3
$35K Sell
985
-249
-20% -$8.55K ﹤0.01% 2988
2016
Q2
$37K Sell
1,234
-12
-1% -$363 ﹤0.01% 2970
2016
Q1
$44K Buy
1,246
+11
+0.9% +$355 ﹤0.01% 2886
2015
Q4
$40K Hold
1,235
﹤0.01% 2949
2015
Q3
$40K Buy
1,235
+10
+0.8% +$376 ﹤0.01% 2993
2015
Q2
$51K Buy
1,225
+135
+12% +$5.69K ﹤0.01% 3003
2015
Q1
$49K Sell
1,090
-1,040
-49% -$43.5K ﹤0.01% 3051
2014
Q4
$79K Buy
2,130
+980
+85% +$35.9K ﹤0.01% 2596
2014
Q3
$41K Hold
1,150
﹤0.01% 2774
2014
Q2
$41K Hold
1,150
﹤0.01% 2664
2014
Q1
$37K Buy
1,150
+160
+16% +$6.12K ﹤0.01% 2621
2013
Q4
$42K Sell
990
-171
-15% -$7.04K ﹤0.01% 2547
2013
Q3
$47K Buy
1,161
+66
+6% +$2.77K ﹤0.01% 2528
2013
Q2
$46K Buy
+1,095
New +$44.3K ﹤0.01% 2425

Other funds holding HAE

PNC Financial Services Group's HAE Position: Q2 2026 in Review

PNC Financial Services Group reduced its Haemonetics (HAE) stake by 1.1% in Q2 2026, selling an estimated $3.15K and leaving 4,587 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #2068.

PNC Financial Services Group first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.47M in Q2 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • PNC Financial Services Group held 4,587 shares of Haemonetics worth $344K as of Q2 2026.
  • PNC Financial Services Group sold 49 Haemonetics shares in Q2 2026, an estimated $3.15K.
  • Haemonetics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2068 holding.
  • PNC Financial Services Group first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
  • PNC Financial Services Group's Haemonetics position peaked at $8.47M in Q2 2019.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.